NCT02181998View on ClinicalTrials.gov

A Trial on Efficacy and Safety of Full Dose Tenecteplase Combined With Unfractionated Heparin (UFH) or Enoxaparin in Acute Myocardial Infarction (AMI) in the Prehospital Setting

PHASE3CompletedINTERVENTIONAL
Enrollment

1,606

Participants

Timeline

Start Date

July 31, 2000

Primary Completion Date

August 31, 2002

Conditions
Myocardial Infarction
Interventions
DRUG

Full dose tenecteplase

DRUG

Unfractioned heparin

DRUG

Enoxaparin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY